Effectiveness of CYP2C19 Genotype-Guided Antiplatelet Therapy Following Neurovascular Endovascular Procedures: A Prospective Non-Randomized Controlled Study

Therapeutics and Clinical Risk Management · Published 2026-07-01 · DOI 10.2147/tcrm.s615918

Free full text

Authors (7)

Shaowen Xu, Xinxin Wang, Guangjun Cui, Miaomiao Li, Guoning Chen, Jinhua Hu, Qizhi Zhang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Xu, S., Wang, X., Cui, G., et al. (2026). Effectiveness of CYP2C19 Genotype-Guided Antiplatelet Therapy Following Neurovascular Endovascular Procedures: A Prospective Non-Randomized Controlled Study. Therapeutics and Clinical Risk Management. https://doi.org/10.2147/tcrm.s615918

Related articles

• The Therapeutic Role of Biologics in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): A Review of the Current Evidence · Therapeutics and Clinical Risk Management · 2026 · Same journal
• Real-World Evidence on Statin Use for Traumatic Brain Injury Associated Degenerative Neurological Disorders · Therapeutics and Clinical Risk Management · 2026 · Same journal
• Anatomical Foundations and Clinical Utility of Personalized Free Ilioinguinal Zone Flap for Hand Skin and Soft Tissue Defect Reconstruction · Therapeutics and Clinical Risk Management · 2025 · Same journal
• The Future of Interventional Keratoconus Management: Perspectives on Integrating Epithelium-on Oxygen-Enriched Cross-Linking into Comprehensive Care Pathways · Therapeutics and Clinical Risk Management · 2026 · Same journal
• Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series · Therapeutics and Clinical Risk Management · 2026 · Same journal
• Comparative Evaluation of 11 Prognostic Scores for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation in Non-Paroxysmal AF: A Retrospective Comparative Analysis · Therapeutics and Clinical Risk Management · 2025 · Same journal
• The ESINEA Study: A Novel Screening Tool for Identifying Patient Safety Incidents and Adverse Events in Hospitalized Patients–An Index-Date Cohort Evaluation · Therapeutics and Clinical Risk Management · 2026 · Same journal
• Effect of Dexmedetomidine Combined with Esketamine on Postoperative Fatigue in Patients Undergoing Total Laparoscopic Hysterectomy: A Single-Center Randomized Double-Blinded Controlled Trial · Therapeutics and Clinical Risk Management · 2026 · Same journal
• Modulating Metabolic Health and Physiological Functions: Advances in Dietary Interventions Targeting Gut Microbiota · Therapeutics and Clinical Risk Management · 2025 · Same journal
• Immune Checkpoint Inhibitors in Breast Cancer: Mechanisms, Biomarkers, and Future Therapeutic Strategies · Therapeutics and Clinical Risk Management · 2026 · Same journal